Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Platelet-released growth factors can reduce inflammation in joint disease.

ILC1-like cells can independently cause alopecia areata.

An HIV patient with IRIS had rare syphilis symptoms affecting skin, eyes, and nerves.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Higher inflammation markers are linked to more severe alopecia areata.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

Inflammation is a key factor in heart disease and targeting it can reduce heart problems.

New cytokine-targeted therapies show promise for treating alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

MicroRNAs could lead to new treatments for skin diseases, but more research is needed.

Cytokine therapy is promising for treating skin conditions like vitiligo and psoriasis.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Intralesional steroid therapy is useful for treating various skin conditions.